8-K Featured Impact 10/10 Earnings

$EL · ESTEE LAUDER COMPANIES INC

November 2, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Estée Lauder reported Q1 FY2027 results with net sales of $3.715B (+7% reported, +6% organic), adjusted EPS of $0.72 (vs. $0.32 prior year), and gross margin of 75.7%. The company raised its full-year FY2027 outlook for sales, margin, and EPS, citing accelerating growth and the impact of its Beauty Reimagined transformation program.

  • Net sales rose 7% YoY to $3.715B, with organic net sales up 6%.
  • Adjusted diluted EPS hit $0.72 vs. $0.32 a year ago, a 125% increase.
  • Gross margin expanded 240 bps to 75.7%, driven by PRGP cost efficiencies and pricing.
  • Adjusted operating margin nearly doubled to 12.1% from 7.3% in the prior-year quarter.
  • Fragrance was the standout category with 20% organic net sales growth.
PeriodQ1 FY2026
ResultBeat
Revenue$3.715B
EPS$0.72

Extended-hours trading pushed shares to $112.00, +2.54% above the regular close, signaling a positive initial reaction to the broad-based beat and raised full-year outlook.

The combination of accelerating revenue growth, dramatic margin expansion, and a raised full-year outlook signals Estée Lauder's turnaround is gaining real traction after years of sluggish performance.

Estée Lauder's margin recovery and Fragrance momentum contrast with a mixed prestige beauty backdrop; share gains in China, Japan, and Korea suggest the Beauty Reimagined turnaround is gaining traction against L'Oréal and LVMH peers.

Foreign currency translation was a 1% headwind to organic net sales; Makeup grew only 1% organically, with Estée Lauder brand declining. The effective tax rate remains elevated at 32.5% (adjusted 31.9%), and transfer-pricing-related unrecognized tax benefits are rising.

$EL

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →